Lenabasum missed mark for systemic sclerosis but may show promise for adjunctive therapyJune 11, 2021Autoimmune DiseasesMedical Dermatology
Intravenous immunoglobulin controls dermatomyositis in phase 3 trialJune 3, 2021Autoimmune DiseasesMedical DermatologyRare Diseases
Rituximab superior to mycophenolate mofetil in pemphigus vulgaris studyMay 24, 2021Medical DermatologyMixed Topics
FDA panel narrowly backs avacopan approvalMay 7, 2021Autoimmune DiseasesMedical DermatologyRare Diseases
In pemphigus, phase 2 results with BTK inhibitor raise hopes for phase 3 trialMay 6, 2021Medical Dermatology
For diagnosing skin lesions, AI risks failing in skin of colorMay 4, 2021Nonmelanoma Skin CancerMelanomaMedical DermatologyDiversity in Medicine
Tofacitinib: Small study shows big cutaneous sarcoidosis responseApril 25, 2021Medical DermatologyMixed Topics
Topical anticholinergic for axillary hyperhidrosis shows fewer side effectsApril 25, 2021Medical Dermatology
Systematic approach to pain helps avoid opioid issues for dermatologistsApril 24, 2021Medical Dermatology
Boosting the presence of darker skin in rheumatology educationApril 21, 2021Diversity in MedicinePsoriatic ArthritisPediatricsMedical Dermatology
Study aims to enhance understanding of ‘tremendously understudied’ prurigo nodularisApril 16, 2021Medical DermatologyPsoriasisAtopic DermatitisMixed Topics
